Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

13.11
Delayed Data
As of 3:59pm ET
 +0.13 / +1.00%
Today’s Change
8.67
Today|||52-Week Range
14.55
+22.52%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.98
Today’s open13.09
Day’s range12.90 - 13.15
Volume466,735
Average volume (3 months)1,104,915
Market cap$1.4B
Dividend yield7.63%
Data as of 3:59pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+111.32%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio20.5
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.19-1.52%
IPXLImpax Laboratories I...+0.65+3.47%
EBSEmergent BioSolution...-0.12-0.33%
ARRYArray Biopharma Inc+0.06+0.77%
Data as of 4:02pm ET, 07/25/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts